SLDE insider Stephen Rohde plans 5,000-share sale

Stephen Rohde filed a notice of proposed sale of SLDE common stock.

Rhea-AI Filing Summary

Stephen Rohde filed a notice of proposed sale of SLDE common stock. The filing lists up to 5,000 shares to be sold through Morgan Stanley Smith Barney LLC on or about August 14, 2026, following a cash-paid stock option exercise on August 6, 2026. It also reports prior sales of 5,000 shares for $105,024.00 on August 6, 2026 and 5,000 shares for $100,000.00 on July 31, 2026.

Key Figures

Planned shares to be sold: 5,000 shares Aggregate market value of planned sale: $109,460.50 Planned sale date: 08/14/2026 +3 more

6 metrics

Planned shares to be sold 5,000 shares Common stock listed for proposed sale under Form 144

Aggregate market value of planned sale $109,460.50 Reported value for 5,000 common shares in the securities information

Planned sale date 08/14/2026 Anticipated sale date for the 5,000-share transaction on NASDAQ

Stock option exercise date 08/06/2026 Date of stock option exercise that generated the 5,000 shares

Recent sale on 08/06/2026 5,000 shares for $105,024.00 Common shares sold during the past 3 months

Recent sale on 07/31/2026 5,000 shares for $100,000.00 Common shares sold during the past 3 months

Key Terms

Form 144, Stock Option Exercise, aggregate market value

3 terms

Form 144 regulatory

"144: Securities To Be Sold"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

Stock Option Exercise financial

"Common | 08/06/2026 | Stock Option Exercise | Issuer"

A stock option exercise is the act of using a previously granted right to buy shares of a company's stock at a specific, predetermined price by paying that price and receiving the shares. It matters to investors because exercising changes who owns the shares (which can dilute existing ownership), can trigger taxable events and shift potential gains or losses, and affects voting power and the company’s outstanding share count—like turning a voucher into an actual product that becomes part of circulating supply.

aggregate market value financial

"5000 | 109460.50 | 116811719 | 08/14/2026"

Aggregate market value is the combined price you would pay to buy all outstanding shares of a company or all companies in a group at current market prices — essentially the sum of each stock’s market capitalization. It matters to investors because it shows the overall size and weight of an investment or sector (like the total cost to buy every piece of a puzzle), helps compare scale across companies or markets, and influences index composition and risk exposure.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the SLDE Form 144 filing by Stephen Rohde disclose?

The filing discloses that Stephen Rohde may sell up to 5,000 shares of SLDE common stock. The shares are to be sold through Morgan Stanley Smith Barney LLC following a stock option exercise on August 6, 2026, with an anticipated sale date of August 14, 2026.

How many SLDE shares is Stephen Rohde planning to sell under this Form 144?

Stephen Rohde plans a potential sale of 5,000 SLDE common shares. These shares are associated with a stock option exercise on August 6, 2026, and the filing lists Morgan Stanley Smith Barney LLC as the broker handling the transaction on or about August 14, 2026.

What were Stephen Rohde’s recent SLDE stock sales before this Form 144?

The filing reports two recent SLDE sales by Stephen Rohde: 5,000 shares for $105,024.00 on August 6, 2026, and 5,000 shares for $100,000.00 on July 31, 2026. These transactions cover securities sold during the past three months.

At what value is the planned 5,000-share SLDE sale reported in the Form 144?

The planned sale of 5,000 SLDE shares is reported with an aggregate market value of $109,460.50. This value appears in the securities information section alongside the broker details and the anticipated sale date of August 14, 2026, on NASDAQ.

How were the SLDE shares to be sold by Stephen Rohde acquired?

The shares to be sold were acquired via a stock option exercise on August 6, 2026. The Form 144 notes the acquisition as “Stock Option Exercise” from the issuer, with the consideration described as cash for the 5,000 shares.

Which broker is handling Stephen Rohde’s planned SLDE share sale?

The filing lists Morgan Stanley Smith Barney LLC Executive Financial Services as the broker for the proposed sale. The office is identified at 1 New York Plaza, 8th Floor, New York, NY 10004, with the SLDE common stock traded on NASDAQ.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/14/2026 - 04:59 PM Accepted by SEC EDGAR 08/14/2026 - 04:58 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001256054
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	SLIDE INSURANCE HOLDINGS, INC.
SEC File Number	001-42707
Address of Issuer	4221 W. Boy Scout Blvd., Suite 200 Tampa FLORIDA 33607
Phone	813-748-2030
Name of Person for Whose Account the Securities are To Be Sold	STEPHEN ROHDE
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	5000	109460.50	116811719	08/14/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	08/06/2026	Stock Option Exercise	Issuer			5000	08/06/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
STEPHEN ROHDE 4221 W. Boy Scout Blvd., Suite 200 Tampa FL 33607	Common	08/06/2026	5000	105024.00
STEPHEN ROHDE 4221 W. Boy Scout Blvd., Suite 200 Tampa FL 33607	Common	07/31/2026	5000	100000.00

144: Remarks and Signature

Remarks
Date of Notice	08/14/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Stephen Rohde
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)